Jabil Inc. Warning Letter Details
Warning LetterJabil Inc.
Recipient Title Chief Executive Officer and Director, 10800 Roosevelt Blvd. N. St. Petersburg , FL 33716 United States, (b)(4)
Issue DateAugust 27, 2026
FEI Number3006503102
Violations4
CountryUnited States
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
OpenSubject
CGMP/Finished Pharmaceuticals/Adulterated